Home ›
Entities
› academia
› Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease
Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease
Research article (Alzheimer s & Dementia Translational Research & Clinical Interventions, 2016) · cited 87× · AI/ML
Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease
Summary
Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease is a scholarly article[1].
Key Facts
Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease. Retrieved May 24, 2026, from https://4ort.xyz/entity/design-of-a-bayesian-adaptive-phase-2-proofofconcept-trial-for-ban2401-a-putative-diseasemodifying-monoclonal-antibody-f
MLA“Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/design-of-a-bayesian-adaptive-phase-2-proofofconcept-trial-for-ban2401-a-putative-diseasemodifying-monoclonal-antibody-f.
BibTeX@misc{4ortxyz_design-of-a-bayesian-adaptive-phase-2-proofofconcept-trial-for-ban2401-a-putative-diseasemodifying-monoclonal-antibody-f_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease}}, year = {2026}, url = {https://4ort.xyz/entity/design-of-a-bayesian-adaptive-phase-2-proofofconcept-trial-for-ban2401-a-putative-diseasemodifying-monoclonal-antibody-f}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease — https://4ort.xyz/entity/design-of-a-bayesian-adaptive-phase-2-proofofconcept-trial-for-ban2401-a-putative-diseasemodifying-monoclonal-antibody-f (retrieved 2026-05-24)
